Niclosamide shows strong antiviral activity in a human airway model of SARS-CoV-2 infection and a conserved potency against the Alpha (B.1.1.7), Beta (B.1.351) and Delta variant (B.1.617.2)

SARS-CoV-2 variants are emerging with potential increased transmissibility highlighting the great unmet medical need for new therapies. Niclosamide is a potent anti-SARS-CoV-2 agent that has advanced in clinical development. We validate the potent antiviral efficacy of niclosamide in a SARS-CoV-2 hu...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiss, Anne, Touret, Franck, Baronti, Cecile, Gilles, Magali, Hoen, Bruno, Nougairède, Antoine, de Lamballerie, Xavier, Sommer, Morten O. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639074/
https://www.ncbi.nlm.nih.gov/pubmed/34855904
http://dx.doi.org/10.1371/journal.pone.0260958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639074/
https://www.ncbi.nlm.nih.gov/pubmed/34855904
http://dx.doi.org/10.1371/journal.pone.0260958

Ejemplares similares